clinical trial · NCT06279221
Litfulo Capsules Special Investigation
Pfizer·—·active not recruiting·n = 487
Alopecia AreataLITFULO
brief summary
The objective of this Study is to confirm the safety during the long-term use of this drug and the effectiveness during the use of this drug under the actual use in the patients treated with this drug.
started
Mar 1, 2024
primary completion
Apr 24, 2030
completion
Apr 24, 2030
last updated
Mar 2, 2026
detailed description
This study is an open-label, multi-center, one arm prospective observational cohort study of patients receiving this drug. The investigators complete the CRF based on the information extracted from the medical record created in daily medical practice.
official title
Litfulo® Capsules Special Investigation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol